Cited by 494Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on BehaviorNeural and Behavioral Psychology Studies

The DOI matches its Crossref record; 137 of the 139 references it cites were found in a registry or an index; 10 of the 73 sources its claims cite were checked for support.

Catecholamine Influences on Dorsolateral Prefrontal Cortical Networks

Open access
Arnsten, Amy F.T.·2011·Biological Psychiatry

Abstract

The symptoms of attention-deficit/hyperactivity disorder (ADHD) involve impairments in prefrontal cortical top-down regulation of attention and behavior. All current pharmacological treatments for ADHD facilitate catecholamine transmission, and basic research suggests that these compounds have prominent actions in the prefrontal cortex (PFC). The dorsolateral PFC is especially sensitive to levels of norepinephrine and dopamine, whereby either too little or too much markedly impairs PFC function. Recent physiological studies have shown that norepinephrine strengthens PFC network connectivity and maintains persistent firing during a working memory task through stimulation of postsynaptic α(2A)-adrenoceptors on PFC neurons. Conversely, dopamine acts at D1 receptors to narrow spatial tuning, sculpting network inputs to decrease noise (i.e., stabilization of the representation). The stimulant medications and atomoxetine appear to enhance PFC function by indirectly increasing these catecholamine actions through blockade of norepinephrine and/or dopamine transporters. In contrast, guanfacine mimics the enhancing effects of norepinephrine at postsynaptic α(2A)-receptors in the PFC, strengthening network connectivity. Stronger PFC regulation of attention, behavior, and emotion likely contributes to the therapeutic effects of these medications for the treatment of ADHD.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

This review argues that dorsolateral prefrontal cortex function depends on an inverted-U level of norepinephrine and dopamine, with norepinephrine α2A receptors strengthening network connectivity and dopamine D1 receptors narrowing spatial tuning. ADHD medications likely work by indirectly increasing or mimicking these catecholamine actions to improve prefrontal top-down regulation.

Key findings

  • Norepinephrine and dopamine both show inverted-U effects on dorsolateral prefrontal working memory: moderate arousal-related release improves function, while depletion/fatigue or stress-level release impairs it. Norepinephrine α2A stimulation enhances delay-period firing for preferred directions by inhibiting cAMP-HCN signaling, whereas α1/β1 stimulation under stress impairs prefrontal function.
  • Dopamine D1/5 stimulation has a complementary sculpting role: optimal levels suppress firing to nonpreferred directions and sharpen spatial tuning, while high D1/5 stimulation suppresses all firing and impairs working memory. D2 receptors mainly affect response-related firing rather than delay-period firing.
  • ADHD medications act through catecholamine mechanisms: methylphenidate blocks norepinephrine and dopamine transporters and is more potent for norepinephrine than dopamine in rat prefrontal cortex; atomoxetine blocks the norepinephrine transporter and raises both norepinephrine and dopamine in prefrontal cortex; guanfacine directly mimics norepinephrine at postsynaptic α2A receptors. Atomoxetine at 40 mg increased right inferior prefrontal activity during a stop-signal task, while a much higher dose impaired go/no-go performance.
  • Blocking α2 receptors in monkey dorsolateral prefrontal cortex reproduces ADHD-like symptoms: yohimbine infusions induced locomotor hyperactivity, no-go commission errors, and working memory deficits. Genetic variants in dopamine β-hydroxylase and the α2A receptor have been associated with ADHD and impaired prefrontal executive function.

Methods

  • Narrative review synthesizing basic and clinical literature on catecholamine modulation of dorsolateral prefrontal cortical networks, with emphasis on working memory circuits.
  • Evidence base includes monkey electrophysiology and iontophoresis during spatial working memory tasks, rodent biochemistry and slice physiology, and human pharmacological, imaging, and genetic studies.
  • Main analysis is conceptual integration of receptor-specific mechanisms (α2A, α1, β, D1/5, D2) and medication effects; no systematic search or meta-analysis is described.

Limitations

  • Stated in the paper: PET imaging cannot detect dopamine interactions with receptors in prefrontal cortex; available D1 drugs act at both D1 and D5, so pharmacological studies cannot separate these mechanisms; D2 response-cell microcircuitry is less understood and it is unknown whether GABA interneurons influence response cells; D1 agonists likely cannot reproduce the dynamic range of endogenous dopamine; the proposed atomoxetine dose-response hypothesis remains to be tested.
  • Stated in the paper: human guanfacine evidence is mixed, with some studies showing cognitive improvement and at least one (Muller et al.) finding no effects on executive or memory functions in healthy volunteers.
  • Evident from the text: this is a narrative review rather than a primary study, with much mechanistic evidence from nonhuman animals and a focus on dorsolateral prefrontal spatial working memory; human causal and prefrontal receptor imaging data are limited.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2011.01.027

Cites

137 of 137 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

10 of 73 cited sources checked · 3 supported · 0 flagged · accuracy not yet measured

Show all 32 claims

  • It may state two separate claims as one. 20
  • Probably not a substantial claim. 1
21 of 21
  • The paper relies on this without support.

    Many symptoms of ADHD arise from dysfunction of the prefrontal cortex and its connections with cortical and subcortical brain regions.

    “As described in this special issue, many of the symptoms of attention-deficit/hyperactivity disorder (ADHD) are thought to arise from dysfunction of the prefrontal cortex (PFC) and its connections with cortical and subcortical brain regions.”
  • The paper relies on this without support.

    Prefrontal cortex networks are able to represent information in the absence of bottom-up external stimulation, but this fragile process is tremendously dependent on the correct neurochemical environment.

    “Prefrontal cortex networks are able to represent information in the absence of bottom-up external stimulation, but this fragile process is tremendously dependent on the correct neurochemical environment, whereby arousal pathways coordinate cognitive state with environmental events.”
2 of 2

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

2 of the 139 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

  1. Matsumoto, 2008, Excitatory and inhibitory responses of midbrain dopamine neurons to cues predicting aversive stimuli, Soc Neurosci Abstr, 691, 24
  2. Eagle, 2010, Beta-adrenoceptor-mediated action of atomoxetine during behavioral inhibition on the stop-signal task in rats, Soc Neurosci Abstr, 508, 510
  3. Arnsten, 1990, Stress impairs prefrontal cortex cognitive function in monkeys: Role of dopamine, Soc Neurosci Abstr, 16, 164

Cited by

Sorted by citations

See all 494

Metadata

Authors
Arnsten, A. F. T.
Affiliations
Yale University (US)
Corresponding author
Arnsten, Amy F.T.
Venue
Biological Psychiatry
Publisher
Elsevier BV
Published
2011-06
Volume
69
Issue
12
Pages
e89-e99
ISSN
0006-3223 (ISSN-L)
OpenAlex
W2091646494
Cited by
493
References
139
Citations by year
2026: 40 · 2025: 40 · 2024: 33 · 2023: 30 · 2022: 14 · 2021: 24 · 2020: 26 · 2019: 32 · 2018: 30 · 2017: 34 · 2016: 36 · 2015: 49 · 2014: 36 · 2013: 26 · 2012: 33
FWCI
4.36
Type
journal article
Language
en
Open access
Locations
  • Biological Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute on Alcohol Abuse and Alcoholism (RL1AA017536)
  • National Institute on Aging (R37AG006036, P01AG030004, R01AG006036, AG06036)
  • National Institute of Mental Health (P50MH068789)
  • National Center for Research Resources (U54RR024350)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
Keywords
attention deficit hyperactivity disorder, dorsolateral prefrontal cortex, catecholamines, norepinephrine, dopamine, alpha2A-adrenoceptor, dopamine D1 receptor, network connectivity, working memory, atomoxetine, guanfacine, stimulant medication, norepinephrine transporter, dopamine transporter
MeSH terms
Atomoxetine Hydrochloride, Adrenergic alpha-Agonists, Animals, Arousal, Attention Deficit Disorder with Hyperactivity, Catecholamines, Cognition, Humans, Memory, Short-Term, Methylphenidate, Models, Neurological, Neural Pathways, Synaptic Transmission, Propylamines, Guanfacine, Prefrontal Cortex, Adrenergic Uptake Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-28, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-28 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review